Warby Parker Inc (WRBY)
12.30
+0.32
(+2.67%)
USD |
NYSE |
May 02, 16:00
12.30
0.00 (0.00%)
After-Hours: 20:00
Warby Parker SG&A Expense (Quarterly): 108.64M for Dec. 31, 2023
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 108.64M |
September 30, 2023 | 112.50M |
June 30, 2023 | 108.86M |
March 31, 2023 | 107.22M |
December 31, 2022 | 102.36M |
September 30, 2022 | 108.09M |
June 30, 2022 | 118.43M |
Date | Value |
---|---|
March 31, 2022 | 123.39M |
December 31, 2021 | 122.15M |
September 30, 2021 | 171.64M |
June 30, 2021 | 86.86M |
March 31, 2021 | 80.76M |
December 31, 2020 | 70.30M |
September 30, 2020 | 105.32M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
70.30M
Minimum
Dec 2020
171.64M
Maximum
Sep 2021
109.04M
Average
108.36M
Median
SG&A Expense (Quarterly) Benchmarks
AptarGroup Inc | 152.78M |
Daxor Corp | -- |
Sanara MedTech Inc | 16.34M |
Precision Optics Corp Inc | 1.933M |
Perspective Therapeutics Inc | 1.694M |